Response Plus Holding PJSC Valuation

Q: What is the Fair Price of RPM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

RPM (AED3.82) is trading below our estimate of [[fair value]] (AED6.55)

Is RPM undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of RPM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: RPM (AED3.82) is trading below our estimate of fair value (AED6.55)

Significantly Below Fair Value: RPM is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RPM?

Key metric: As RPM is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for RPM. This is calculated by dividing RPM's market cap by their current earnings.
What is RPM's PE Ratio?
PE Ratio	15.3x
Earnings	د.إ49.97m
Market Cap	د.إ764.00m

RPM key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.9x
Enterprise Value/EBITDA	11.2x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does RPM's PE Ratio compare to its peers?

The above table shows the PE ratio for RPM vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	37.8x
GMPC Gulf Medical Projects Company (PJSC)	20.4x	n/a	د.إ1.3b
TMCLIFE TMC Life Sciences Berhad	31.2x	n/a	RM 888.4m
AONC American Oncology Network	75.1x	n/a	US$175.0m
5NG Healthway Medical	24.5x	n/a	S$213.2m
RPM Response Plus Holding PJSC	15.3x	n/a	د.إ764.0m

Price-To-Earnings vs Peers: RPM is good value based on its Price-To-Earnings Ratio (15.3x) compared to the peer average (42.3x).

Price to Earnings Ratio vs Industry

How does RPM's PE Ratio compare vs other companies in the Asian Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: RPM is good value based on its Price-To-Earnings Ratio (15.3x) compared to the Asian Healthcare industry average (21x).

Price to Earnings Ratio vs Fair Ratio

What is RPM's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RPM PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	15.3x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate RPM's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.